Literature DB >> 10749768

Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra.

M D Josephs1, C C Solorzano, M Taylor, J J Rosenberg, D Topping, A Abouhamze, S L Mackay, E Hirsch, D Hirsh, M Labow, L L Moldawer.   

Abstract

A complete understanding of the role for endogenously produced interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and IL-1 receptor antagonist (IL-1ra) in the acute phase response to inflammation remains unknown. In the present studies, knockout mice lacking either a functional IL-1 type I receptor (IL-1RI(-/-)), a TNF type I receptor (TNFR-I(-/-)), or both IL-1 type I and TNF type I receptors (IL-1RI(-/-)/TNFR-I(-/-)) received a turpentine abscess. Additional mice deficient in IL-1ra protein (IL-1ra(-/-)) or overexpressing IL-1ra protein (IL-1ra(tg)) were similarly treated. After a turpentine abscess, IL-1 receptor knockout mice exhibited an attenuated inflammatory response compared with wild-type or animals lacking a functional TNFR-I. Mice overexpressing IL-1ra also had an attenuated hepatic acute phase protein response, whereas IL-1ra knockout mice had a significantly greater hepatic acute phase response. We conclude that the inflammatory response to a turpentine abscess is the result of a balance between IL-1ra expression and IL-1 binding to its type I receptor. Endogenously produced IL-1ra plays a central role in mitigating the magnitude of the IL-1-mediated inflammatory response and, ultimately, the outcome to a turpentine abscess.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749768     DOI: 10.1152/ajpregu.2000.278.4.R824

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  12 in total

1.  Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Authors:  Omar Touzani; Herve Boutin; Rosalind LeFeuvre; Lisa Parker; Andy Miller; Giamal Luheshi; Nancy Rothwell
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

2.  Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size.

Authors:  Cecilia M Devlin; George Kuriakose; Emmet Hirsch; Ira Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis.

Authors:  Maripat Corr; David L Boyle; Lisa M Ronacher; Brian R Lew; Lisa G van Baarsen; Paul P Tak; Gary S Firestein
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

Review 4.  New drugs for the anorexia-cachexia syndrome.

Authors:  Mellar P Davis
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

5.  Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease.

Authors:  Giuseppe Patti; Andrea D'Ambrosio; Aldo Dobrina; Giordano Dicuonzo; Carlo Giansante; Nicola Fiotti; Antonio Abbate; Gianfranco Guarnieri; Germano Di Sciascio
Journal:  J Thromb Thrombolysis       Date:  2002-10       Impact factor: 2.300

6.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

7.  Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial.

Authors:  Aminah Jatoi; James Egner; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Shaker R Dakhil; James A Mailliard; George G Klee; James E Krook
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

Review 8.  Postoperative pain management and proinflammatory cytokines: animal and human studies.

Authors:  Yehuda Shavit; Keren Fridel; Benzion Beilin
Journal:  J Neuroimmune Pharmacol       Date:  2006-09-29       Impact factor: 4.147

9.  Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA.

Authors:  Andrea Mayado; Elisa Torres; Maria D Gutierrez-Lopez; Maria I Colado; Esther O'Shea
Journal:  J Neuroinflammation       Date:  2011-11-24       Impact factor: 8.322

10.  Time-dependent effects of localized inflammation on peripheral clock gene expression in rats.

Authors:  Susan Westfall; Argel Aguilar-Valles; Valérie Mongrain; Giamal N Luheshi; Nicolas Cermakian
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.